CRF Connect Logo

Coronary

Clinical Indications and Science Learning Series

Late-Breaking Trials and Science

Advertisement

Coronary >
Late-Breaking Trials and Science

Episodes

Artificial Intelligence-Based Fully Automated Quantitative Coronary Angiography Versus Optical Coherence Tomography Guidance for Coronary Stent Implantation (FLASH): Multicenter, Randomized Controlled Non-Inferiority Trial
Artificial Intelligence-Based Fully Automated Quantitative Coronary Angiography Versus Optical Coherence Tomography Guidance for Coronary Stent Implantation (FLASH): Multicenter, Randomized Controlled Non-Inferiority Trial
19 min.
FLASH Trial: Editorial Commentary
FLASH Trial: Editorial Commentary
8 min.
The TARGET-IV Trial: International Multicenter Randomized Assessment of the Firehawk® Rapamycin Eluting Coronary Stent System
The TARGET-IV Trial: International Multicenter Randomized Assessment of the Firehawk® Rapamycin Eluting Coronary Stent System
15 min.
Prospective, Multicenter, Open-Label, Randomized Controlled Trial of 3-Month Versus 12-Month Dual Antiplatelet Therapy After Implantation of the Biodegradable Polymer Firehawk Sirolimus-Eluting Coronary Stent: Primary Outcomes of the TARGET DAPT Trial
Prospective, Multicenter, Open-Label, Randomized Controlled Trial of 3-Month Versus 12-Month Dual Antiplatelet Therapy After Implantation of the Biodegradable Polymer Firehawk Sirolimus-Eluting Coronary Stent: Primary Outcomes of the TARGET DAPT Trial
9 min.
Quantitative Flow Ratio or Fractional Flow Reserve for Guiding Coronary Revascularization
Quantitative Flow Ratio or Fractional Flow Reserve for Guiding Coronary Revascularization
23 min.
FAVOR III: Editorial Commentary
FAVOR III: Editorial Commentary
12 min.
ECLIPSE: A Large-scale, Randomized Trial of Orbital Atherectomy vs. Conventional Balloon Angioplasty in Severely Calcified Coronary Arteries Prior to DES Implantation
ECLIPSE: A Large-scale, Randomized Trial of Orbital Atherectomy vs. Conventional Balloon Angioplasty in Severely Calcified Coronary Arteries Prior to DES Implantation
15 min.
CLEAR SYNERGY (OASIS 9) Trial: A 2x2 Factorial Randomized Controlled Trial of Colchicine Versus Placebo and Spironolactone Versus Placebo in Patients With Myocardial Infarction: The Results of the Colchicine Factorial
CLEAR SYNERGY (OASIS 9) Trial: A 2x2 Factorial Randomized Controlled Trial of Colchicine Versus Placebo and Spironolactone Versus Placebo in Patients With Myocardial Infarction: The Results of the Colchicine Factorial
10 min.
CLEAR SYNERGY (OASIS 9) Trial: Editorial Commentary
CLEAR SYNERGY (OASIS 9) Trial: Editorial Commentary
10 min.
Comparison of Noncompliant Balloon With Drug-Coating Balloon Angioplasties for Side Branch After Provisional Stenting for Patients With True Coronary BIFurcation Lesions: The Prospective, Multicenter, Randomized DCB-BIF Trial
Comparison of Noncompliant Balloon With Drug-Coating Balloon Angioplasties for Side Branch After Provisional Stenting for Patients With True Coronary BIFurcation Lesions: The Prospective, Multicenter, Randomized DCB-BIF Trial
16 min.
Early Administration of Heparin at First Medical Contact Versus in the Cathlab for STEMI Patients Undergoing Primary Percutaneous Coronary Intervention (HELP-PCI): A Multicenter, Randomized Trial
Early Administration of Heparin at First Medical Contact Versus in the Cathlab for STEMI Patients Undergoing Primary Percutaneous Coronary Intervention (HELP-PCI): A Multicenter, Randomized Trial
19 min.
Comparison of Puncture Success Rate Between Distal Radial Access and Transradial Access in Patients With ST-Elevation Myocardial Infarction
Comparison of Puncture Success Rate Between Distal Radial Access and Transradial Access in Patients With ST-Elevation Myocardial Infarction
15 min.
1-Year and Landmark 6-12 Month Clinical Outcomes Among Patients in Complex Lesion Subsets Treated With DynamX Bioadaptor Compared to a Contemporary Drug Eluting Stent From the INFINITY-SWEDEHEART Randomized Clinical Trial
1-Year and Landmark 6-12 Month Clinical Outcomes Among Patients in Complex Lesion Subsets Treated With DynamX Bioadaptor Compared to a Contemporary Drug Eluting Stent From the INFINITY-SWEDEHEART Randomized Clinical Trial
18 min.